21 C.F.R. §1301.12 - Separate registrations for separate locations

Cite as21 C.F.R. §1301.12
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
6 cases
  • Wedgewood Village Pharmacy, Inc. v. Ashcroft, Civil Action No. 03-5242(JBS).
    • United States
    • United States District Courts. 3th Circuit. United States District Courts. 3th Circuit. District of New Jersey
    • December 15, 2003
    ...manufactures, distributes, or dispenses controlled substances or list I chemicals." 21 U.S.C. § 822(e). The companion regulation, 21 C.F.R. § 1301.12(a), also provides that "[a] separate registration is required for each principal place of business or professional practice at one general lo......
  • Morall v. Drug Enforcement Admin., 04-1367.
    • United States
    • United States Courts of Appeals. United States Court of Appeals (District of Columbia)
    • June 24, 2005
    ...§ 827(a)(1) (2000). They are also required to hold a DEA registration at any location where they dispense controlled substances, see 21 C.F.R. § 1301.12 (2004), and to store controlled substances "in a securely locked, substantially constructed cabinet," id. § 1301.75. Finally, physicians w......
  • United States v. Butterbaugh, C14-515 TSZ
    • United States
    • United States District Courts. 9th Circuit. United States District Court (Western District of Washington)
    • August 5, 2015
    ...see Minute Order (docket no. 31), for the following reasons. First, the Government's discussion concerning the different versions of 21 C.F.R. § 1301.12(b)(3) addressed an issue raised by Butterbaugh in his response to the motion for summary judgment, which is an appropriate use of a reply.......
  • Becker v. Drug Enforcement Admin.
    • United States
    • United States Courts of Appeals. United States Court of Appeals (6th Circuit)
    • October 3, 2013
    ...and dispensed without obtaining a Drug Enforcement Administration Certificate of Registration, in violation of 21 U.S.C. § 822(e) and 21 C.F.R. § 1301.12; (2) Becker's continued administering of controlled substances at the Avon location after having received notice this was in violation of......
  • Request a trial to view additional results
1 firm's commentaries
  • In Proposed Rulemaking, DEA Looks to Expand Mobile Narcotic Treatment Options
    • United States
    • JD Supra United States
    • February 28, 2020
    ...health and patient safety benefits. The proposed rule is largely based upon this authority. As currently structured under DEA statute, 21 CFR 1301.12, each “principal place of business or professional practice” must be registered as part of the dispensation of controlled substances, schedul......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT